Literature DB >> 29620924

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.

Jeffrey R Strawn1, Paul E Croarkin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29620924     DOI： 10.1089/cap.2018.0012

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  3 in total

1.  Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents.

Authors:  Aiswarya Laks Nandakumar; Jennifer L Vande Voort; Paul A Nakonezny; Scott S Orth; Magdalena Romanowicz; Ayse Irem Sonmez; Jessica A Ward; Sandra J Rackley; John E Huxsahl; Paul E Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-11-02       Impact factor: 2.576

2.  The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.

Authors:  Sarah A Mossman; Jeffrey A Mills; John T Walkup; Jeffrey R Strawn
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-04-21       Impact factor: 3.031

3.  A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.

Authors:  Robert L Findling; Emily McCusker; Jeffrey R Strawn
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-05-27       Impact factor: 2.576
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.